Triple-receptor agonist, GLP-1, GIP, and glucagon pathways Extended half-life for stable pharmacokinetic profiles Subject of multiple ongoing clinical trials Pre-filled pen for precise, repeatable delivery Janoshik-verified, 99% purity guaranteed What Researchers Say Frequently Asked Questions Retatrutide (LY3437943) is an investigational triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors
How these powerful medications can be used, misused, or abused
Most people hear "GLP-1" and think gut hormone
They called the chemical substance 'secretin'
The actions of PP include delaying gastric emptying, inhibition of gallbladder contraction, and attenuation of pancreatic exocrine secretions